Google will partner with Included Health to launch a nationwide randomized study evaluating how conversational artificial intelligence performs in real-world virtual care workflows.
Here are four things to know about the study:
- Pending Institutional Review Board approval, the study will recruit consented participants nationwide and use a randomized controlled trial design to assess how the AI performs in clinical workflows at scale, moving beyond simulated environments and retrospective data.
- According to a Feb. 3 press release, the study aims to measure the capabilities and limitations of conversational medical AI in managing patient interactions in virtual care workflows, compared with standard clinical practice, across a range of patient concerns and geographic regions.
- Google said the research is part of a phased approach intended to generate more evidence on patient and clinician experience, safety and usefulness as the technology is tested in increasingly real-world settings.
- The companies said the nationwide randomized study is intended to raise the standard of evidence generation for medical AI by shifting from lab-based demonstrations and small feasibility work to a large-scale trial in real-world virtual care.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.